Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

A Phase III multicenter randomized double-blind trial to evaluate the efficacy and safety of HSK44459 tablets in idiopathic pulmonary fibrosis, with the study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• HSK44459

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: IPF | Phase 3 | Status: NOT_YET_RECRUITING